CFI and Dawkins Foundation Urge FTC to Stop Homeopathy’s False Advertising
November 23, 2015
The Center for Inquiry and the Richard Dawkins Foundation for Reason & Science are urging the Federal Trade Commission to put an end to false advertising by the manufacturers of homeopathic products. They point to the overwhelming scientific consensus that these pseudoscientific alternative remedies have no effect (other than a placebo effect) on any condition, and harm consumers who rely on them in lieu of real, science-based medicine.
CFI and the Dawkins Foundation, jointly filing comments, remind the FTC that its mandate is “to protect the American public, not to safeguard the sales of relics from the cabinets of 18th century medicine.” They argue that the FTC should use its authority to stop manufacturers from falsely advertising homeopathy’s safety or efficacy until such claims can be scientifically proven. The FTC itself has recently expressed its own concern about the harm to American consumers posed by the unsubstantiated claims of the homeopathy industry.